Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.

Author: GallagherJ C

Paper Details 
Original Abstract of the Article :
The long-term safety and efficacy of synthetic 1,25-(OH)2D3 (calcitriol; Rocaltrol) in the treatment of women with type 1 osteoporosis is being assessed in a randomized trial. Patients were allocated in double-blind fashion to 1,25-(OH)2D3 or matching placebo. Initially, the calcium intake was adjus...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0026-0495(90)90268-h

データ提供:米国国立医学図書館(NLM)

The Quest for Bone Health: Exploring the Effects of Calcitriol

In the vast desert of medical research, the search for effective osteoporosis treatments continues. This particular study delves into the metabolic effects of synthetic calcitriol (Rocaltrol) in postmenopausal women. The researchers utilized a randomized, double-blind trial, which is like navigating a complex maze of scientific methodology, to assess the long-term safety and efficacy of calcitriol. Their goal was to find the ideal dose to achieve a balance between strengthening bones and minimizing potential side effects. They discovered that increasing the dose of calcitriol led to hypercalcemia and hypercalciuria, a bit like a desert oasis that is too abundant and can actually be harmful. To address this, they strategically reduced calcium intake, finding that the optimal maintenance dose of calcitriol averaged 0.675 micrograms/day. Their research also revealed that this long-term therapy was not associated with nephrotoxicity, providing a glimmer of hope for those seeking long-term solutions.

A Balanced Oasis: Calcitriol's Potential for Bone Health

This research shines a light on the potential benefits of calcitriol in managing postmenopausal osteoporosis. They found that the ideal dose of calcitriol can be carefully managed to improve bone health without harming the kidneys. The results suggest that this medication could provide a much-needed oasis of relief for women facing the challenges of osteoporosis.

Navigating the Desert of Bone Health: Understanding Calcitriol's Role

Calcitriol's role in bone health is complex, much like the intricate network of dunes in a desert. While it can help strengthen bones, it's crucial to find the right dosage and monitor potential side effects. This study provides a valuable roadmap for clinicians and patients navigating the complexities of osteoporosis treatment.

Dr. Camel's Conclusion

This study is a valuable oasis in the vast desert of osteoporosis research. Calcitriol has the potential to strengthen bones, but we must carefully navigate the potential side effects like a skilled desert explorer. The results of this study emphasize the importance of individualized treatment plans and ongoing monitoring to optimize outcomes.

Date :
  1. Date Completed 1990-05-16
  2. Date Revised 2019-07-25
Further Info :

Pubmed ID

2325568

DOI: Digital Object Identifier

10.1016/0026-0495(90)90268-h

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.